Omega-3 fatty acids for CHD with depression

JAMA

Volumn 303, Issue 9, 2010, Pages 836-

  Anghelescu, Ion ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

OMEGA 3 FATTY ACID; PLACEBO; SERTRALINE;

BECK DEPRESSION INVENTORY; DEPRESSION; DRUG EFFICACY; HAMILTON SCALE; HUMAN; ISCHEMIC HEART DISEASE; LETTER; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 77649204741     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2010.190     Document Type: Letter

References (5)

1. Carney RM, Freedland KE, Rubin EH, Rich MW, Steinmeyer BC, Harris WS. Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease. JAMA. 2009;302(15):1651-1657.
2. Demyttenaere K, De Fruyt J. Getting what you ask for: on the selectivity of depression rating scales. Psychother Psychosom. 2003;72(2):61-70.
3. Gill D, Hatcher S. Antidepressants for depression in people with physical illness. Cochrane Database Syst Rev. 2000;(2):CD001312.
4. Nemets B, Stahl Z, Belmaker RH. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry. 2002;159(3):477-479.
5. Peet M, Horrobin DF. Adose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry. 2002;59(10):913-919.